Johnson & Johnson (NYSE: JNJ) reported earnings on Jan. 22. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 30 (Q4), Johnson & Johnson met expectations on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew significantly.

Gross margins contracted, operating margins were steady, net margins grew.

Revenue details
 Johnson & Johnson notched revenue of $17.56 billion. The 17 analysts polled by S&P Capital IQ foresaw a top line of $17.67 billion on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $16.26 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.19. The 21 earnings estimates compiled by S&P Capital IQ predicted $1.16 per share. GAAP EPS of $0.91 for Q4 were much higher than the prior-year quarter's $0.08 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 65.8%, 140 basis points worse than the prior-year quarter. Operating margin was 20.3%, about the same as the prior-year quarter. Net margin was 14.6%, 1,330 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $17.63 billion. On the bottom line, the average EPS estimate is $1.40.

Next year's average estimate for revenue is $72.20 billion. The average EPS estimate is $5.50.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 13,550 members out of 14,043 rating the stock outperform, and 493 members rating it underperform. Among 3,288 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 3,220 give Johnson & Johnson a green thumbs-up, and 68 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Johnson & Johnson is outperform, with an average price target of $75.42.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Johnson & Johnson. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.